You are here: Industry Insights > Vaccine

News List

HALIX and University of Oxford collaborate for GMP manufacturing of COVID-19 Vaccine expresspharma
April 17, 2020
The nCoV-19 vaccine is based on the Jenner Institute’s adenovirus vaccine vector (ChAdOx1) technology, which was chosen as the most suitable candidate for a SARS-CoV-2 (COVID-19) vaccine.
China approves two experimental coronavirus vaccines to enter clinical trials expresspharma
April 16, 2020
The vaccines are being developed by a Beijing-based unit of Nasdaq-listed Sinovac Biotech , and by the Wuhan Institute of Biological Products, an affiliate of state-owned China National Pharmaceutical Group.
NantKwest and ImmunityBio work on Covid-19 vaccines and drugs pharmaceutical-technology
April 16, 2020
NantKwest and its sister firm ImmunityBio have partnered for the development of potential vaccines and therapeutics against Covid-19.
Applied DNA supplies Covid-19 vaccine candidates for preclinical tests pharmaceutical-technology
April 16, 2020
Applied DNA Sciences has shipped five Covid-19 LinearDNA vaccine candidates to Italy-based Takis Biotech for preclinical testing in animals.
Sanofi and GSK partner to develop Covid-19 vaccine pharmaceutical-technology
April 15, 2020
Sanofi and GlaxoSmithKline (GSK) have signed a letter of intent for a partnership focused on developing an adjuvanted vaccine for Covid-19.
Jenner Institute, MilliporeSigma to Scale Up Covid-19 Vax Production contractpharma
April 15, 2020
Develops a rapid, scalable platform following good manufacturing practices and using disposable technologies.
Immunomic partners EpiVax and PharmaJet on Covid-19 vaccine pharmaceutical-technology
April 14, 2020
Biotechnology firm Immunomic Therapeutics has partnered with EpiVax and PharmaJet to develop a vaccine candidate against Covid-19 infection.
iBio Expands COVID-19 Vaccine Collaboration contractpharma
April 14, 2020
Now includes the Infectious Disease Research Institute to help lead pre-clinical development and clinical trial oversight.
China's CanSino Bio advances COVID-19 vaccine into phase 2 on preliminary safety data Fiercepharma
April 13, 2020
In the global race to develop an effective vaccine to protect people against the novel coronavirus, China’s CanSino Bio has leapt ahead.
Pfizer identifies lead coronavirus drug candidate pharmaceutical-technology
April 13, 2020
Pfizer has announced progress in its research programme to develop antivirals and vaccine for the Covid-19 coronavirus infection.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page